B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 700 KRW 1.99% Market Closed
Market Cap: 433.5B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

Net Margin
BioPlus Co Ltd

33.3%
Current
35%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
33.3%
=
Net Income
17.8B
/
Revenue
53.5B

Net Margin Across Competitors

Country KR
Market Cap 433.5B KRW
Net Margin
33%
Country JP
Market Cap 6.9T JPY
Net Margin
24%
Country CH
Market Cap 37.7B CHF
Net Margin
12%
Country DK
Market Cap 179.1B DKK
Net Margin
19%
Country US
Market Cap 15.8B USD
Net Margin
11%
Country CN
Market Cap 52B CNY
Net Margin
42%
Country CA
Market Cap 6.3B USD
Net Margin
-8%
Country KR
Market Cap 9.1T KRW
Net Margin
-358%
Country US
Market Cap 6.2B USD
Net Margin
29%
Country US
Market Cap 5.7B USD
Net Margin
9%
Country UK
Market Cap 4.5B GBP
Net Margin
7%
No Stocks Found

BioPlus Co Ltd
Glance View

Market Cap
433.5B KRW
Industry
Health Care

BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.

Intrinsic Value
15 791.58 KRW
Undervaluation 51%
Intrinsic Value
Price
B

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
33.3%
=
Net Income
17.8B
/
Revenue
53.5B
What is the Net Margin of BioPlus Co Ltd?

Based on BioPlus Co Ltd's most recent financial statements, the company has Net Margin of 33.3%.